Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-05

Clinical Trial Update: Boost rTMS for Auditory Verbal Hallucinations [NA]

View source ↗

Summary

Clinical trial update for rTMS in auditory verbal hallucinations associated with schizophrenia; study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RTMS (Repetitive transcranial magnetic stimulation)

Snippet

Sponsor: Northwell Health | Conditions: Schizophrenia, Auditory Hallucination | NA | Status: TERMINATED | Results posted: 2021-05-05